Introduction
The corpus callosum (CC) axon tract connects the cerebral hemispheres through the corticoseptal boundary (CSB) in mice and humans and CC malformation is associated with cognitive and neurological conditions in humans (Donahoo and Richards, 2009) . Precisely controlled radial glial cell (RGC) somal translo-cation from the ventricular zone (VZ) of the CSB to its pial surface generates midline zipper (MZ) and indusium griseum (IG) astroglial populations required for cerebral hemisphere fusion and subsequent CC axon navigation (Shu and Richards, 2001; Inatani et al., 2003; Shu et al., 2003; Smith et al., 2006; Moldrich et al., 2010; Clegg et al., 2014; Gobius et al., 2016) . The movement of RGC astroglial precursors from the glial wedge (GW) to the IG (GW¡IG translocation) forms an astroglial guidepost population that secretes Slit2 to guide CC axons across the telencephalic midline.
Fibroblast growth factors (FGFs) are an evolutionarily ancient family comprising 23 genes in mice and humans of which Fgf20 , and Fgf22 in mice) encode "canonical" FGFs that function as paracrine signaling molecules and bind promiscuously to cell surface FGF receptors (FGFRs encoded by Fgfr1-4 in mice) to elicit an extracellular signal regulated kinase (ERK)/mitogen activated kinase (MAPK) response via activating phosphorylation of ERK¡phospo-ERK (pERK). Canonical FGFs are further subdivided into five subfamilies based on phylogeny and Fgf8 subfamily members Fgf8 and Fgf17 are transcribed in the developing CSB in close spatiotemporal proximity posing the question of how they are coordinated (Guillemot and Zimmer, 2011; Ornitz and Itoh, 2015) . Under normal conditions, GW¡IG translocation is primarily attributed to Fgf8 and needs to be tightly regulated to ensure that correct numbers of RGCs leave the GW and reach the IG. Deviation above (or below) normal FGF/ERK signaling levels induces too many (or too few) RGCs to translocate with consequent disruption to CC development (Smith et al., 2006; Wang et al., 2012; Clegg et al., 2014; Gobius et al., 2016) . Although Fgf17 plays a role in patterning the developing telencephalon, its importance for CC development is less clear and no CC phenotype has been reported in Fgf17 Ϫ / Ϫ embryos (Cholfin and Rubenstein, 2007, 2008) . Because Fgf8 and Fgf17 are the principal Fgfs transcribed in vicinity of the GW and both activate ERK, mechanisms must exist to keep the total amount of Fgf protein (Fgf8 protein ϩ Fgf17 protein) at the correct level to generate the correct levels of ERK activation for astroglial precursor RGCs to translocate in appropriate numbers.
Heparan sulfate (HS), the carbohydrate component of cell surface and extracellular matrix (ECM) HS proteoglycans, is a negatively charged sulfated polysaccharide that binds canonical FGFs in the ECM to regulate their movement and half-life and also functions as an obligate FGF coreceptor in FGF:FGFR:HS ternary signaling complexes on the cell surface (Guillemot and Zimmer, 2011; Balasubramanian and Zhang, 2016) . HS biosynthesis is in two stages, Ext enzymes polymerize uronic acid -glucosamine disaccharides making linear [uronic acid -glucosamine] n HS polymers which are then modified by the enzymatic addition (by HS sulfotransferases, HSTs) or removal (by HS sulfatases, Sulfs) of sulfate groups at specific positions on the disaccharide residues. There are four classes of HST enzymes, Hs2st, Hs3st, Hs6st, and Ndst, each adding sulfate to a specific position; for example, Hs2st only adds sulfate to the carbon atom in position 2 of uronic acid, generating 2-O HS sulfation. Although work in a variety of systems shows that HS itself can play roles both in the transmission of FGF signals through the ECM (non-cell-autonomous role) and the cellular response to FGF (cell-autonomous role), the potential for specific forms of HS sulfation to selectively regulate FGFs by regulating the physical interaction between HS and FGF proteins is much less well understood (Allen et al., 2001 Qu et al., 2011 Qu et al., , 2012 Toyoda et al., 2010; Christian, 2012; Zhang H et al., 2012; Ramsbottom et al., 2014; Chan et al., 2015 Chan et al., , 2017 Balasubramanian and Zhang, 2016) .
The HS code hypothesis states that different forms of HS sulfation can encode specific instructions Kreuger et al., 2006) . In this study, we discover that 2-O HS sulfation catalyzed by Hs2st functions non-cell autonomously at the developing telencephalic midline to suppress FGF/ERK signaling that drives the somal translocation of astroglial precursors required for normal CC development. We also present evidence that Hs2st plays a selective role by modulating the physical interaction between Fgf17 protein and HS and selectively suppressing Fgf17 protein levels at the CSB.
Materials and Methods
Animals. All mice were bred in-house according to Home Office UK legislation and licenses approved by the University of Edinburgh Ethical Review Committees and Home Office. Embryos analyzed in this study were of either sex. Animal husbandry was in accordance with UK Animals (Scientific Procedures) Act of 1986 regulations. The Hs2st LacZ (Hs2st Ϫ )-null allele comprised a LacZ gene trap vector integrated into the Hs2st locus, the Hs6st1 LacZiresPLAP (Hs6st1 Ϫ )-null allele comprised a LacZiresPLAP gene trap vector integrated in the Hs6st1 locus, and both were genotyped by PCR as described previously (Bullock et al., 1998; Pratt et al., 2006; Cre (septal deletion) or Emx1 CreER (cortical deletion) driver alleles (Inatani et al., 2003; Kessaris et al., 2006; Rubin et al., 2010; Stanford et al., 2010) . CreER activity was induced at embryonic day 9.5 (E9.5) by administering tamoxifen (dissolved in corn oil using a sonicator) to pregnant dams by intraperitoneal injection (120 mg/kg dose). Lineages of cells in which Cre was active were visualized using a Rosa26R-floxedstop-EGFP reporter allele (Sousa et al., 2009) .
Ex vivo assays. Ex vivo culture experiments were performed essentially as described previously (Niquille et al., 2009 ) Explants were cultured on nucleopore polycarbonate membranes (Whatman) floating on 1 ml of neurobasal medium (Life Technologies) supplemented with L-glutamine, glucose, and penicillin/streptomycin) at 37°C with 5% CO 2 in a humidified incubator. Brains were dissected from embryos in oxygenated Earle's balanced salt solution (Life Technologies), embedded in lowmelting-point agarose, sliced using a vibratome (Leica VTS-1000), and transferred to modified Eagle's medium (MEM; Life Technologies) with 5% fetal bovine serum for 1 h. For CC axon navigation assays, 400-mthick E17.5 coronal slices incorporating the CC axon tract were prepared and frontal cortex explants from -GFP ϩ slices were transplanted into the equivalent region in -GFP Ϫ slices before culturing in neurobasal medium for 72 h, fixation in 4% paraformaldehyde (PFA), and GFP immunofluorescence. For glial translocation experiments, 10 mg/ml BrdU dissolved in PBS was injected intraperitoneally into pregnant dams with E14.5 litters, which were killed 1 h later and 350 m coronal slices incorporating the CSB prepared for culture. In Fgf17 bead experiments, Affi-Gel blue gel (Bio-Rad) beads presoaked in 100 g/ml recombinant Fgf17 protein (R&D systems) or 5 mg/ml BSA (Sigma-Aldrich) overnight at 4°C were implanted into the slice, one Fgf17 and one BSA bead on either side of the midline just below the GW, and the MEM was replaced with neurobasal medium. For the FGFi culture, MEM was replaced with neurobasal medium containing either 25 M SU5402, 0.1% DMSO (FGFi) or 0.1% DMSO (control). Slices were cultured for 2 or 48 h, fixed in 4% PFA, and 10 m frozen sections were prepared for immunodetection or in situ hybridization. Glial migration out of the VZ toward the pial surface was quantified from BrdU/Sox9 immunofluorescence micrographs by demarcating the basal edge of the VZ (easily identified by Sox9 staining) with a line and counting the number of Sox9 ϩ ;BrdU ϩ cells that had crossed this line. This allowed us to count glial (Sox9 ϩ ) cells that had incorporated BrdU (BrdU ϩ ) when they were in the VZ before the start of the culture and subsequently exited the VZ and migrated toward the midline over the 2 d culture period when the cultures were exposed to experimental substances (SU5402, DMSO, Fgf17 protein, or BSA). Four or six sections were quantified per slice moving rostrally from the most caudal section in which the GW could be identified on both sides of the section.
Immunodetection. Embryonic mouse brains were removed and fixed in 4% PFA in PBS overnight at 4°C, cryoprotected in 30% sucrose in PBS, embedded in OCT, and 10 m coronal frozen sections were cut using a cryostat (Leica). Immunohistochemistry was performed as described previously (Clegg et al., 2014) . Primary antibodies: goat anti-GFP (diluted 1/250; Abcam); rabbit anti-Sox9 (1/500; Cell Signaling Technology); rat anti-L1 (1/200; Millipore); rabbit anti-GFAP (1/200 Dako); rabbit anti-Hs2st (1/50; Abcam ab103120); rabbit anti-Fgf17 (1/1000; Abcam ab187982); and rabbit anti-pErk1/2 (1/200; Cell Signaling Technology). Secondary antibodies were as follows: donkey anti-goat Alexa Fluor 488, donkey anti-rabbit Alexa Fluor 568, and goat anti-rat 568 (all used at a dilution of 1/200 and from Invitrogen). Fluorescently labeled sections were counterstained with DAPI (Invitrogen). For Hs2st and pErk1/2 antibody staining, goat anti-rabbit biotin secondary antibody (1/200; Vector Laboratories) was used and staining was visualized using a standard avidin-biotin diaminobenzidine (DAB) staining procedure. The Fgf17 immunofluorescence was performed using exactly the same protocol as described previously for Fgf8 except that the Fgf8 antibody was replaced with the Fgf17 antibody (Toyoda et al., 2010; Clegg et al., 2014) . Briefly, slides were first washed in acetone for permeabilization, rabbit Fgf17 antibody was applied, and the TSA Plus Fluorescence System Kit (PerkinElmer) was used for fluorescence detection.
In situ hybridization. In situ hybridization was performed on 10 m frozen sections as described previously (Wallace and Raff, 1999) using digoxigenin-labeled riboprobes for Slit2 and Fgf17 (Xu et al., 1999; Erskine et al., 2000) .
Imaging. Fluorescence-labeled sections were imaged using either a Leica AF6000 epifluorescence microscope coupled to a Leica DFC360 digital camera or a Nikon Ti: E Inverted confocal microscope. DAB stained and in situ hybridized sections were imaged using a Leica DLMB microscope coupled to a Leica DFC480 color digital camera.
Fgf17 protein quantification. Fgf17 fluorescence was quantified from E14.5 Hs2st ϩ/ϩ ;Hs6st1 ϩ/ϩ , Hs2st
, and Hs6st1 Ϫ / Ϫ coronal sections that had been processed for Fgf17 immunofluorescence in parallel and imaged under identical conditions in parallel using the same method as described previously for Fgf8 protein quantification (Chan et al., 2017) . For each section, ImageJ was used to measure mean fluorescence intensity in a 100 ϫ 150 m box drawn at the CSB encompassing the Fgf17 expression domain. For each embryo, quantification was performed for three sections along the rostrocaudal axis and averaged. CreER embryos was performed as described previously (Clegg et al., 2014) . A counting box measuring 200 ϫ 200 m was placed on images of coronal sections at the midline with the top edge at the dorsal extent of Sox9 ϩ cells at the IG and the numbers of Sox9 ϩ cells in the box counted. For each embryo, quantification was performed for three sections along the rostrocaudal axis and averaged.
IG
Western blotting. Western blotting was performed as described previously (Clegg et al., 2014) . Primary antibodies were as follows: rabbit anti-Hs2st (1/500; Abcam ab103120) and mouse anti-␤-actin (1/5000; Abcam). Secondary antibodies were as follows: goat anti-mouse Alexa Fluor 680 (Invitrogen) and goat anti-rabbit 800 (Li-Cor) .
Ligand and carbohydrate engagement (LACE) assay. The LACE assay was performed as described previously (Allen et al., 2001; Allen and Rapraeger, 2003; Chan et al., 2015) . Briefly, frozen sections were incubated in 0.05% NABH 4 /PBS for 15 min. After several washes in PBS, sections were incubated in 0.1 M glycine at 4°C overnight. Some sections were incubated with Heparitinase I (Seikagaku) before proceeding. All Fgf and Fgfr-Fc proteins were purchased from R&D Systems. Sections were then treated with 1% BSA/TBS solution for 10 min before incubation with 3 M recombinant mouse Fgf17 and 9 M recombinant human Fgfr1a(IIIc)-Fc or 30 nM recombinant mouse Fgf8b and 100 nM recombinant human Fgfr3 (IIIc)-Fc at 4°C overnight. Fgf17 or Fgf8 were omitted from some assays. Fluorescent LACE signal was generated by incubation with 1/200 anti-human IgG (Fc-specific) Cy3 (Sigma-Aldrich) in 1% BSA/TBS. Hs2st
, and Hs6st1 Ϫ / Ϫ material that had been processed for each LACE assay condition in parallel was imaged under identical conditions in parallel. For each section, ImageJ was used to measure mean fluorescence intensity in a 100 ϫ 150 m box drawn encompassing the CSB. Background signal was quantified from control LACE experiments from which the FGF ligand was omitted and these values were used for background subtraction. For each embryo, quantification was performed for three sections along the rostrocaudal axis and averaged.
Data analysis and statistics. Results are expressed as mean Ϯ SEM. The statistical test and sample size (n) for each experiment are specified in the figure legends. Statistical comparison between two groups was performed with a t test. Statistical comparison between more than two groups was performed with ANOVA followed by post hoc t test. p Ͻ 0.05 was considered significant.
Results
Hs2st protein is widely expressed in the developing cerebral cortex and at the telencephalic midline To establish potential sites of action of Hs2st in CC development, we first examined the distribution of cells expressing Hs2st protein and contributing to developing CC structures using Hs2st immunohistochemistry at E14.5 ( Fig. 1A-D ) and E18.5 ( Fig.  1E -M ) spanning the period of CC axon tract development. Macroscopically, Hs2st protein distribution closely resembles the Hs2st-LacZ reporter staining previously reported, with widespread Hs2st expression in the developing cerebral cortex and at the CSB at both E14.5 and E18.5 ( Fig. 1 A, E, boxed areas indicate regions shown at higher magnifications in B-D and F-M ) . Subcellularly, the Hs2st signal is punctate consistent with the expected localization of Hs2st in the Golgi apparatus (arrows point to Hs2st
ϩ puncta in higher-magnification insets in Fig. 1 B, F,P). At E14.5, there was a high density of Hs2st ϩ puncta at the CSB in the GW region where IG astroglial RGC prescursors reside (Fig. 1B , with boxed area shown as higher-magnification inset with arrows indicating Hs2st ϩ puncta), with the density falling toward the pial surface although Hs2st ϩ puncta were visible. There were many Hs2st ϩ puncta in the VZ of the cerebral cortex ( Fig. 1C) and also in the cortical plate ( Fig. 1D ), indicating that many cortical progenitors and postmitotic neurons express Hs2st. At E18.5, Hs2st is expressed by many cells in the IG (Fig. 1F ) and at the apical surface of the VZ at the GW (Fig. 1G) , septum ( Fig. 1H ) , and ventral telencephalon ( Fig. 1I ) , with the number of Hs2st expressing VZ cells diminishing as distance from the ventricle increases. In the cerebral cortex, Hs2st is expressed by many cells close to the apical surface of the VZ (Fig. 1J ). Large numbers of postmitotic cortical neurons outside of the VZ express Hs2st and, moving toward the pial surface, the density of Hs2st ϩ puncta varies with laminar position [cf. Ϫ / Ϫ telencephalic protein extracts (Fig.  1R ). To conclude, Hs2st protein is present in developing cerebral cortex, the source of CC axons, as well as in progenitor and post-mitotic cells of the CSB region constituting the environment through which midline crossing CC axons navigate. Hs2st expression analysis suggests multiple potential sites of action for 2-O HS sulfation in CC development.
Slit2-expressing IG is expanded in Hs2st
؊ / ؊ embryos We previously reported that increased numbers of astroglia at the pial surface of the Hs2st Ϫ / Ϫ CSB stemmed from precocious glial translocation and found no evidence that changes in cell prolif- eration or death contributed to this phenotype Clegg et al., 2014) . To determine whether there is an expansion of the IG in Hs2st Ϫ / Ϫ embryos, we compared the expression of Slit2 mRNA, a marker of GW and IG glia but not MZ glia, between Hs2st ϩ/ϩ and Hs2st Ϫ / Ϫ embryos at E16.5 (Shu and Richards, 2001; Shu et al., 2003) . In Hs2st ϩ/ϩ embryos Slit2 ϩ cells form a compact focus at the IG that increases in size moving caudally ( Fig. 2 A, C, E, Slit2 expression domain at IG indicated by brackets). In Hs2st Ϫ / Ϫ embryos, the Slit2 expression domain is greatly expanded at the pial surface along the rostrocaudal axis ( Fig. 2 B, D,F , expanded Slit2 expression domain indicated by brackets). We conclude that an expansion of the Slit2 ϩ IG astroglial population makes a major contribution to the Hs2st
Cell autonomy of HS and 2-O HS sulfation in astroglial precursor somal translocation and CC development
We next exploited conditional mutagenesis of Hs2st or Ext1 to experimentally uncouple specific functions of 2-O sulfation from more general functions of HS in astroglial precursor translocation and CC development. Widespread expression of HS and 2-O HS sulfation leaves open the possibility that each regulates GW¡IG astroglial precursor somal translocation cell autonomously by modulating the response to signals, non-cell autonomously by regulating the supply of signals, or both. To resolve this, we identified two Cre alleles, Zic4
Cre and Emx1
CreER , that drive LoxP-mediated mutagenesis in the astroglial lineage or in their cellular environment, respectively, and used them to conditionally ablate either HS (Ext1 LoxP mutagenesis) or 2-O HS (Hs2st LoxP mutagenesis) sulfation to test for cell-autonomous or non-cell-autonomous functions. We refer to these as "Zic4 lineage" and "Emx1 lineage," respectively, and next present their characterization using a floxed-stop GFP reporter that turns on GFP expression in Cre-expressing cells and their descendants before describing experiments where they are used to conditionally generate loss-of-function mutations in Ext1
Fl or Hs2st Fl alleles (Inatani et al., 2003; Kessaris et al., 2006; Rubin et al., 2010; Sousa et al., 2009; Stanford et al., 2010) .
Characterization of Zic4 and Emx1 lineages
The septum is of Zic4 lineage, as shown by strong expression of the GFP reporter (Fig. 3A) . The GFP signal in the intermediate zone of the cerebral cortex (asterisks in Fig. 3A ) is due to GFP ϩ thalamocortical axons that project from Zic4-lineage cells in the thalamus and cells of subcortical origin as described previously (Rubin et al., 2010) . At the midline, GFP ϩ cells of the Zic4 lineage are predominantly located ventral to the CSB (dashed lines in Fig.  3B ), but there is also GFP expression in the IG (boxed area "D" in Fig. 3B ). Sox9 is a transcription factor that marks the nuclei of RGCs in the VZ and differentiated astroglia in the IG and MZG and we previously showed that the positioning of Sox9 ϩ cells is of critical importance for the development of the CC (Clegg et al., 2014) . Combining GFP with Sox9 immunostaining reveals the contribution of the Zic4 lineage to the CSB astroglial populations. There is a sharp boundary (dashed line in Fig. 3C ) in the VZ of the CSB between Sox9 ϩ ;GFP ϩ cells (arrowheads in Fig. 3C ) on the septal side and Sox9 ϩ ;GFP Ϫ cells (arrows in Fig. 3C ) on the cortical side. Virtually all the Sox9 ϩ cells in the IG (Fig. 3D ) and MZG ( Fig.  3E ) are also GFP ϩ (arrowheads in Fig. 3D ,E), indicating that these cells are of the Zic4 lineage. These data show that the Zic4 lineage contributes Sox9 ϩ cells to the septal VZ and, strikingly, is the sole source of Sox9 ϩ astroglia in the IG (Fig. 3F ). To mark the Emx1 lineage, tamoxifen was administered to Emx1
CreER embryos harboring the floxed-stop GFP reporter at E9.5 so that early Emx1 expressing cerebral cortex progenitors and their descendants were rendered GFP ϩ . Examination of the expression of the GFP reporter shows that, as expected, the developing cerebral cortex and CC axons are of Emx1 lineage (Fig.  3G) and that, at the midline, GFP expression is predominantly located dorsal to the CSB (dashed lines in Fig. 3H ). Higher magnification shows that there is a sharp boundary between GFP ϩ and GFP Ϫ cells at the VZ of the CSB (dashed line in Fig. 3I ). Combining Sox9 and GFP immunostaining reveals the contribution of the Emx1 lineage to Sox9 ϩ cells. Sox9 ϩ ;GFP ϩ cells (arrowheads in Fig. 3I ) populate the VZ on the cortical side of the boundary with Sox9 ϩ ;GFP Ϫ cells on the septal side (arrows in Fig. 3I ) , showing that the Emx1 lineage contributes Sox9 ϩ cells exclusively to the cortical side of the VZ. All Sox9 ϩ cells in the IG (Fig. 3J ) and MZ (Fig. 3K ) are GFP Ϫ (arrows in Fig. 3 J, K ), indicating that the Emx1 lineage does not contribute Sox9 ϩ cells to the IG. These data show that the Emx1 lineage contributes Sox9 ϩ cells to the cortical VZ, but no cells of this lineage contribute Sox9 ϩ astroglia to the IG (schema in Fig. 3L ).
Ext1 is required by both Emx1-and Zic4-lineage cells for CC development To determine the cellular requirement for HS, we deleted Ext1, which is essential for HS synthesis, in the Zic4 or Emx1 lineages. In control embryos, L1 immunostaining labels axons in the U-shaped CC, whereas GFAP staining labels midline astroglial structures (Fig. 4A , with higher magnification of IG and GW in D, G). Removing HS from either the Zic4 lineage (Fig. 4B , with higher magnification of IG and GW in Fig. 4 E, H ) or the Emx1 lineage ( Fig. 4C , with higher magnification of IG and GW in Fig.  4 F, I ) generates a severe CC agenesis phenotype (Zic4 Cre ;Ext1
Fl/Fl n ϭ 3/3). In Emx1 conditional mutants (Emx1
CreER ;Ext1 Fl/Fl ), CC axons fail to cross the midline and form Probst bundles short of the midline (Fig. 4B) . GFAP astroglial cells are present in the IG (Fig. 4E ) and at the GW (Fig.  4H ) in a pattern grossly similar to that of controls (cf . Fig. 4 
D, G and E, H ). In Zic4 conditional mutants (Zic4
Cre ;Ext1 Fl/Fl ), CC axons approach the midline but fail to cross (Fig. 4C , with higher magnification of IG and GW in F, I ). Astroglial populations in Zic4 conditional mutants are obviously disrupted, with less intense GFAP staining at the midline (cf. IG region in Fig. 4 D, F ) and more GFAP at the GW than in controls (arrows in Fig. 4I ; cf. Fig. 4G,I ), suggesting that, in these embryos, astroglial precursors translocate less efficiently to the IG and instead remain in the GW. The cerebral cortex of Zic4
Cre ;Ext1 Fl/Fl brains was thinned and the ventricles were enlarged (cf. Fig. 4 A, C) and this cre allele combined with a lox-stop GFP reporter has been used to label cell populations at E18.5. Zic4 cre labels cells of the septum (asterisks in 3A mark GFP in cortex). B-E, Zic4 cre labels cells ventral to the CSB (dashed line, B,C) including Sox9 expressing cells (arrowheads, C), but is not expressed by Sox9 expressing cells dorsal to the CSB (arrows, C). hydrocephalus-like phenotype is intriguing because the cerebral cortex is not of the Zic4 lineage, indicating a non-cellautonomous mechanism by which HS regulates cerebral cortex development. The FGFR1/FGF2 LACE assay detects endogenous HS on tissue sections by forming ternary complexes with exogenously added FGF2 and FGFR1 (red LACE signal in Fig. 4J -O) (Allen et al., 2001; Chan et al., 2015) . HS is ubiquitously expressed in both cortical and septal compartments of control telencephalon (Fig. 4J , higher magnification of CSB in M ) and, as intended, HS synthesis is blocked in the cortex and cortical axons of Emx1
CreER ;Ext1 Fl/Fl embryos (Fig. 4K , CSB shown at higher magnification in N, with arrows indicating HS-deficient cortical . HS expression is required within both Emx1 and Zic4-lineage cells for CC formation. A-I, Immunofluorescence for L1 (red) at E18.5 labels the CC, whereas GFAP (green) labels glia. In control embryos, the U-shaped CC has formed and is flanked by glia at the IG and GW (A, D, G) . In Ext1 fl/fl Emx1 creER embryos, CC axons do not cross the midline, whereas glia at the IG and GW appear largely unaffected (B, E, H ). In Ext1 fl/fl Zic4 cre embryos, CC axons do not cross the midline, whereas glia appear depleted at the IG and form abnormal bundles at the GW (C, F, I ). J-O, FGFR1/FGF2 LACE assay is used to detect the presence of HS. In control embryos, the LACE signal can be seen throughout the telencephalon and is of similar intensity within both the cortex and the septum (J, M ). In Ext1 fl/fl Emx1 creER embryos, the LACE signal is significantly reduced within the cortex (K, N ). In 
region) and in the septum of Zic4
Cre ;Ext1 Fl/Fl embryos (Fig. 4L , higher magnification of CSB in O, with arrows indicating HSdeficient septum). Predigesting tissue sections with heparitinase eliminated the LACE signal (data not shown), confirming the specificity of this assay for detecting HS. The salient conclusions from the Ext1 conditional mutagenesis for the current study are that HS is indispensable from both the Zic4 and the Emx1 lineages for CC development and that removing HS from the Zic4 lineage inhibits Zic4 lineage astroglia from reaching the IG region. 
Hs2st is required by

;Zic4
Cre ) displayed neither CC agenesis nor midline astroglial disorganization; the control embryo shown in Figure 5 ( A, D,G,J ; D and G are reproduced from Fig. 3 H, J ) is of the Hs2st ϩ/ϩ ;Emx1 CreER genotype. The CC and the midline astroglial structures form normally in Hs2st fl/fl ;Zic4 Cre conditional mutants and the organization of L1 ϩ axons and GFAP ϩ astroglia are indistinguishable from control embryos (6/6 embryos) (cf. Fig. 5 B, A) . 
Sox9
ϩ cell counts confirm that the numbers of Sox9 ϩ cells in the IG are not significantly different from control Hs2st ϩ/ϩ embryos (Fig. 5M, CreER embryos, the CC fails to form in ϳ50% of cases and embryos either had a severe phenotype (Fig. 5C , 5/9 embryos) or appeared completely unaffected (Fig. 5CЈ, 4/9 embryos) . CC axons form Probst bundles on either side of the telencephalic midline, and the GFAP ϩ IG is expanded (asterisks in Fig. 5C ). The anatomy and incomplete penetrance of the CC phenotype in Hs2st fl/fl ;Emx1 CreER embryos closely resemble constitutive null Hs2st Ϫ / Ϫ embryos, indicating that Hs2st function within the Emx1 lineage is sufficient for normal CC development Clegg et al., 2014) . As in control Hs2st ϩ/ϩ ;Emx1
CreER embryos (Fig. 5 D, G CreER embryos despite retaining Hs2st function allows us to conclude a non-cell-autonomous requirement for Hs2st in the translocation of astroglial precursors to the IG.
The salient conclusions from these conditional mutagenesis experiments are that, although the Zic4-lineage astroglia do require Ext1 to form midline astroglial structures, they do not require Hs2st, strongly suggesting that, whereas these Zic4-lineage cells require HS on their cell surface to respond to translocation signals, there is no need for the HS to be 2-O sulfated. In contrast, Hs2st is absolutely required in the surrounding Emx1-lineage cells, indicating a non-cell-autonomous mechanism by which 2-O HS sulfation controls the transmission of translocation signals to the Zic4-lineage astroglial precursors.
Hs2st is not required cell autonomously by CC axons to navigate the midline
The conditional mutagenesis experiments showed that Hs2st has a non-cell-autonomous role in GW¡IG somal translocation, but because Hs2st is expressed throughout the cerebral cortex, did not resolve whether there is an additional cell autonomous requirement in CC axon navigation. To solve this, we performed ex vivo transplantation experiments in which cerebral cortical tissue from transgenic mice ubiquitously expressing GFP, which efficiently labels axons of GFP ϩ cells, was transplanted into GFP Ϫ telencephalic slices containing the CC axon pathway and CSB structures (Pratt et al., 2000; Niquille et al., 2009) . When WT E17.5 GFP ϩ cortical explants are transplanted into age-matched GFP Ϫ WT cortical slices, GFP ϩ axons extend across the telencephalic midline, forming the characteristic U shape of the CC and reaching the cortex of the opposite hemisphere (n ϭ 3/3 cultures, arrows in Fig. 6A ,D point to crossing axons). When Hs2st Ϫ / Ϫ GFP ϩ cortical explants are transplanted into GFP Ϫ WT slices, axons are able to cross the midline to reach the opposite hemisphere in a manner indistinguishable from that seen in the WT¡WT transplants (n ϭ 4/4 cultures, arrows in Fig. 6B ,E point to crossing axons). In contrast, when GFP ϩ WT cortical explants are transplanted into GFP
Ϫ
Hs2st
Ϫ / Ϫ slices, axons are unable to reach the opposite cortical hemisphere and instead remain within the cingulate cortex or invade the septum (n ϭ 6/6 cultures, Fig. 6 C,F , arrowheads point to axons growing into the septum), resembling the in vivo CC phenotype observed in Hs2st Ϫ / Ϫ embryos Clegg et al., 2014) . In all cultures, a few axons grew into the septum (arrowheads in Fig. 6D-F) . Schematics summarizing these experiments are shown in Figure 6 , G-I. These data show that 2-O HS sulfation is not required cell autonomously by CC projection neurons for axon guidance across the midline, strongly suggesting that disorganization of midline guidepost astroglial cells is the primary cause of the Hs2st Ϫ / Ϫ CC agenesis phenotype.
Abnormally high FGF/ERK signaling causes the Hs2st
؊ / ؊ precocious astroglial translocation phenotype We previously reported a correlation between hyperactive ERK signaling at the CSB and precocious somal translocation of astroglia to the midline in Hs2st Ϫ / Ϫ embryos, but we did not formally establish that this stemmed from hyperactive FGF/ERK signaling (Clegg et al., 2014; Chan et al., 2017) . To address this, we used an ex vivo assay in which coronal WT or Hs2st Ϫ / Ϫ telencephalic slices incorporating the CSB were cultured on floating membranes for long enough to allow somal translocation to the midline and attempted to rescue the Hs2st Ϫ / Ϫ phenotype by pharmacological abrogation of FGF/ERK signaling. WT or Hs2st Ϫ / Ϫ E14.5 slices were cultured in the presence of the Fgfr1 inhibitor SU5402 dissolved in DMSO (FGFi treatment) to inhibit FGF/ERK signaling or in DMSO alone (untreated control) for 48 h (Fig. 7A) . To aid subsequent identification of translocating cells, a subpopulation RGCs undergoing S-phase in the VZ at E14.5 were labeled just before culturing with a single pulse of BrdU. Immunohistochemistry for pErk (brown stain in Fig.  7 B, D, F, H ) confirms inhibition of FGF/ERK signaling in both FGFi treated WT and Hs2st Ϫ / Ϫ cultures (Fig. 7 D, H ) compared with untreated cultures (Fig. 7 B, F ) , showing that FGF signaling through Fgfr1 accounts for ERK phosphorylation in both genotypes. This demonstrates that ERK hyperactivation in Hs2st Ϫ / Ϫ embryos does not stem from an FGF-independent mechanism for ERK activation (Clegg et al., 2014; Chan et al., 2017) . After 48 h, some Sox9 ϩ cells (red) had left the VZ and translocated to the midline in untreated WT cultures (arrow in Fig. 7C) , with many more populating the midline in untreated Hs2st Ϫ / Ϫ cultures (arrow in Fig. 7G ), validating that our ex vivo assay replicates the in vivo Hs2st Ϫ / Ϫ phenotype. Consistent with our hypothesis, FGFi treatment of both WT and Hs2st Ϫ / Ϫ cultures resulted in a large decrease in Sox9 ϩ cells reaching the midline (cf. Fig. 7 E, I and C,G) . We quantified glial translocation by counting the numbers of Sox9 ϩ cells born in the VZ at E14.5 (Sox9 ϩ ;BrdU ϩ cells, yellow; inset in Fig. 7C , E, G,I shows higher magnification) that had exited the VZ toward the midline (VZ demarcated by dotted line in Fig. 7C, E, G,I ) after 2 d in culture. Counts of BrdU ϩ ;Sox9 ϩ cells showed that glial translocation was significantly greater in Hs2st Ϫ / Ϫ compared with WT cultures along the rostrocaudal axis (dark purple and green lines in Fig.  7J ) and in both cases was almost completely suppressed by FGFi treatment (pale purple and green lines in Fig. 7J ) .
We conclude that the precocious glial translocation phenotype in Hs2st
Ϫ / Ϫ embryos is caused by hyperactive FGF/ERK signaling from E14.5 on. Together with our Hs2st conditional mutagenesis experiments demonstrating a non-cell-autonomous role for Hs2st in astroglial precursor translocation, we hypothesize that Hs2st normally suppresses the supply of FGF proteins to translocation competent astroglial precursors in the GW.
Hs2st suppresses Fgf17 protein levels
We next sought to identify an FGF protein that is targeted by Hs2st. Despite its well known role in CC development, Fgf8 protein levels are not significantly increased at the CSB of Hs2st
embryos, forcing us to consider other FGFs (Clegg et al., 2014; Chan et al., 2017) . A promising candidate is Fgf17, a member of the Fgf8 subfamily transcribed at the CSB in a similar pattern to Fgf8 (Cholfin and Rubenstein, 2008; Zhang X et al., 2012) . Fgf17 is a canonical FGF that binds to HS, so it is potentially regulated via its interaction with HS and is known to play a role in patterning the telencephalon, although its role in CC development has not been fully characterized (Cholfin and Rubenstein, 2007; Hoch et al., 2015; Li and Kusche-Gullberg, 2016). We hypothesized that Hs2st normally suppresses Fgf17 protein and predicted that Fgf17 protein levels would be increased at the Hs2st Ϫ / Ϫ CSB. We compared the expression of Fgf17 protein in the developing CSB of WT and Hs2st Ϫ / Ϫ embryos at three developmental stages, E12.5, E14.5, and E16.5, spanning the interval of midline glial translocation. At E12.5, telencephalic Fgf17 protein is restricted to the CSB region with no obvious difference between WT and Hs2st Ϫ / Ϫ (cf. Fig. 8A1,B1 and A2,B2) . By E14.5, there is an expanded Fgf17 protein domain at the CSB of Hs2st Ϫ / Ϫ embryos (cf. Fig. 8D1,E1 and D2,E2; *E2 marks the expanded Fgf17 protein domain). Quantification of Fgf17 immunofluorescence shows a significant ϳ2-fold increase in Fgf17 protein levels in this region of Hs2st Ϫ / Ϫ CSB (Fig. 8W , cf. blue and green bars). At E16.5, Fgf17 protein is much closer to detection threshold than at the earlier stages in both genotypes (Fig. 8G1,G2,H1,H2 ) although the increased protein spread in the mutant persists (* in Fig. 8H2 ), indicating that the Hs2st Ϫ / Ϫ CSB is exposed to a prolonged overdose of Fgf17 protein spanning E14.5-E16.5. We next examined Fgf17 mRNA at the CSB to determine whether the increase in Fgf17 protein in Hs2st Ϫ / Ϫ CSB was underpinned by altered Fgf17 gene expression. There was no evidence for this at E12.5 or E14.5, when the Fgf17 mRNA expression pattern remained similar between Hs2st ϩ/ϩ and Hs2st Ϫ / Ϫ embryos (cf. Fig. 8C1,C2 and F1,F2) ; however, the expression domain of Fgf17 mRNA is increased in E16.5 Hs2st Ϫ / Ϫ CSB (cf. Fig. 8I1and I2 , * in I2 marks expanded Fgf17 mRNA domain). This subsequent increase in Fgf17 mRNA in the E16.5 Hs2st Ϫ / Ϫ CSB indicates that the Hs2st Ϫ / Ϫ phenotype has a transcriptional component or that there are more cells expressing Fgf17 mRNA in the expanded Hs2st Ϫ / Ϫ IG, although this cannot be the primary event because it is not apparent at E14.5, the stage at which we previously showed that precocious astroglial precursor translocation was well under way in Hs2st Ϫ / Ϫ embryos (Clegg et al., 2014) . Mosaic analysis (Fig. 5) indicated that Hs2st function in the Emx1 lineage negatively regulates a signal promoting GW¡IG translocation of Zic4-lineage glial cells by a non-cell-autonomous mechanism and Fgf17 expression analysis (Fig. 8) makes Fgf17 a strong candidate for the signal. Based on this, we hypothesized that Fgf17 is expressed in cells surrounding the Zic4-lineage cells and performed detection of Fgf17 mRNA or protein in E14.5 WT embryos in which the Zic4 lineage is labeled GFP ϩ . Fgf17 mRNA is expressed at the GW and the IG (Fig. 8J ) and higher-power magnification shows that, in the VZ, GFP ϩ cells express little if any Fgf17 mRNA and, conversely, cells expressing the highest levels of Fgf17 mRNA are GFP Ϫ (Fig. 8K1-K3 , arrows indicate GFP ϩ cell location). This complementarity between Fgf17 mRNA-expressing and Zic4-lineage cells is preserved at the IG (Fig. 8L1-L3 , arrows indicate GFP ϩ cell location). Fgf17 protein predominates at the IG (Fig. 8M ) and higher-power magnification shows that, although Fgf17 protein is barely detectable at the GW (Fig. 8N1-N3 ), there are a number of much more highly Fgf17-expressing cells at the IG and these cells are GFP Ϫ , confirming that they do not belong to the Zic4 lineage (Fig. 8O1-O3 , arrows indicate GFP ϩ cell location). Interestingly, although cells in the GW and IG express comparable levels of Fgf17 mRNA (cf. Fig. 8K1,L1 ), the expression of Fgf17 protein is much higher in the IG (cf. Fig. 8N1,O1) , suggesting a posttranscriptional repression selectively at the GW. Our identification of Hs2st as a repressor of Fgf17 protein levels at this stage makes Hs2st a strong candidate; indeed, closer examination of Hs2st expression using the Hs2st-LacZ reporter shows that Hs2st is expressed in a GW High -IG Low pattern (Fig. 8P , also apparent in the Hs2st immunohistochemistry; Fig. 1B) complementary to the GW Low -IG High Fgf17 protein distribution. Together, these data bolster the idea that Hs2st acts to suppress Fgf17 protein supply to Zic4-lineage cells via a posttranscriptional mechanism.
We conclude that Hs2st primarily suppresses the level and spread of Fgf17 protein emanating from the Emx1 lineage in the CSB. untreated (n ϭ 3 embryos for each condition). For both genotypes, FGFi treatment significantly reduced the number of Sox9/BrdU ϩ cells that exit the VZ and moved toward the IG at one or more rostrocaudal position [significant differences due to FGFi treatment within each genotype indicated on graph as *p Ͻ 0.05, **p Ͻ 0.01; F (3, 32) ϭ 31.00, p ϭ 0.0000000014, two-way ANOVA, followed by t test with Sidak's correction for multiple comparisons at each positon along the rostrocaudal axis. WT FGFi vs WT untreated: position 1 (t (16) (Clegg et al., 2014; Chan et al., 2017) . However, we were unable to detect increased expression of Fgf17 protein (cf. Fig. 8Q1,R1 and Q2,R2 and T1,U1 and T2,U2) or Fgf17 mRNA (cf. Fig. 8S1,S2 and V1,V2) in Hs6st1 Ϫ / Ϫ compared with WT CSB at either E14.5 or E16.5. Quantification of Fgf17 immunofluorescence shows unchanged Fgf17 protein levels in this region of Hs6st1 Ϫ / Ϫ CSB (Fig. 8W , cf. blue and purple bars). These data demonstrate that the negative relationship between Hs2st and Fgf17 is selective in vivo because it does not apply to Hs6st1.
Exogenously applied Fgf17 phenocopies the Hs2st
؊ / ؊ astroglial translocation phenotype Our data suggest that the Hs2st Ϫ / Ϫ phenotype stems from abnormally high levels of Fgf17 protein at the CSB, causing FGF/ ERK hyperactivation and precocious somal translocation to the IG. This requires that Hs2st Ϫ / Ϫ CSB cells are competent to respond to Fgf17 protein and that application of ectopic Fgf17 triggers precocious glial translocation, neither of which has been previously established. We redeployed the CSB ex vivo culture assay (Fig. 7) with the modification that beads soaked in either recombinant Fgf17 protein (Fgf17 treatment) or in BSA (control) were implanted into coronal slices of CSB region on either side of the midline (Fig. 9A) . WT or Hs2st Ϫ / Ϫ slices implanted with Fgf17 and BSA beads were cultured for 2 h before processing for Fgf17 (green signal) and pErk (red signal) double immunofluorescence (Fig. 9B) . In both WT and Hs2st Ϫ / Ϫ cultures, Fgf17 protein was detectable adjacent to the edge of the bead (green signal) and this activated ERK phosphorylation in a similar pattern (red signal) with no obvious differences between WT and Hs2st Ϫ / Ϫ , indicating that Hs2st Ϫ / Ϫ CSB tissue is competent to respond to Fgf17 (Fig. 9B, top row) . The lack of Fgf17 or pERK signal in the BSA control (Fig. 9B , bottom row) confirms Fgf17 antibody specificity and that pERK activation was specifically induced by exogenously applied Fgf17. We performed Sox9/ BrdU analysis (exactly as described above for the FGFi experiments; Fig. 7 ) to assess the impact of experimentally introduced Fgf17 on astroglial translocation to the midline in WT CSB slices after 48 h in culture and the results were dramatic. The side with the Fgf17-bead showed many more Sox9 ϩ (red) cells in the IG region (large arrow on right side of Fig. 9C ) than the side with the BSA bead (smaller arrow on left side of Fig. 9C ). Quantification of Sox9 ϩ ;BrdU ϩ (yellow) cells (Fig. 9D shows higher magnification of IG region) confirmed a significant increase in astroglial translocation to the midline along the rostrocaudal axis on the side exposed to Fgf17 [Fig. 9E , cf. green (Fgf17) with black (control) lines]. An important function of IG glia is to secrete Slit2 and repulsively guide CC axons in the correct trajectory across the midline. At E16.5, Slit2 mRNA is normally expressed in the IG region and, in Hs2st Ϫ / Ϫ embryos, the midline Slit2 expression domain is expanded (cf. Fig. 2C ,E and D, F; Slit2 expression domain is bracketed). Experimentally introduced Fgf17 is sufficient to phenocopy this aspect of the Hs2st Ϫ / Ϫ phenotype in our ex vivo assay because the side exposed to the Fgf17 bead has a much larger Slit2 domain than the BSA-treated side [cf. left (control) and right (Fgf17) bracketed areas in Fig. 9F ], consistent with precocious translocation of excessive numbers of Slit2 ϩ IG glia. We conclude that Hs2st Ϫ / Ϫ CSB tissue is competent to respond to Fgf17 protein and abnormally high levels of Fgf17 protein are sufficient to phenocopy the Hs2st Ϫ / Ϫ astroglial translocation phenotype consistent with the model presented in Figure 10 .
Hs2st selectively facilitates physical interaction between Fgf17 protein and HS
Our in vivo data show that Hs2st suppresses the levels of Fgf17 protein and that this represents a selective interaction between Hs2st-mediated 2-O HS sulfation and Fgf17 protein levels in vivo because Hs2st does not suppress the levels of the closely related Fgf8 protein, and Hs6st1, which catalyzes 6-O HS sulfation, does not suppress Fgf17 protein levels (Clegg et al., 2014; Chan et al., 2017) (Fig. 8) . However, these in vivo experiments do not resolve whether differential sulfation has a correspondingly direct selective effect on the physical interaction between HS and Fgf17. To test the hypothesis that Hs2st has a selective effect on the binding of Fgf17 protein to HS molecules, we turned to a biochemical assay, the LACE assay, which probes the physical interaction between HS and FGF proteins by quantifying the ability of endogenous HS in tissue sections to form Fgf:Fgfr:HS complexes with exogenously added Fgf protein and Fgfr ectodomain fused to an Fc tag for immunofluorescent detection (Allen et al., 2001; Chan et al., 2015) . We used the Fgf17:Fgfr1 LACE assay to compare the binding of Fgf17 protein to HS in WT, Hs2st Ϫ / Ϫ , and Hs6st1 Ϫ / Ϫ CSB tissue at E14.5 and E16.5 to test the hypothesis that Fgf17:HS physical interaction is selectively sensitive to loss of 2-O HS sulfation in Hs2st Ϫ / Ϫ tissue ( Fig. 11A-J, O) . We used the Fgf8:Fgfr3 LACE assay to compare the binding of Fgf8 protein to HS in WT and Hs2st Ϫ / Ϫ CSB tissue at E14.5 to test the hypothesis that the Fgf8:HS physical interaction is insensitive to loss of 2-O HS sulfation in Hs2st Ϫ / Ϫ tissue ( Fig. 11K-N, P) . In both E14.5 and E16.5 WT tissue, the Fgf17:Fgfr1 and Fgf8: Fgfr3 LACE assays produced a strong LACE signal (Fig. 11 A, F,K , with higher magnification of boxed areas enclosing CSB region shown in AЈ, FЈ,KЈ) . Control experiments show this LACE signal was drastically reduced by pretreating the tissue with heparitinase to digest HS (Fig. 11 D, I ,M, with higher magnification of CSB in DЈ,IЈ,MЈ) or omitting Fgf17 or Fgf8 protein from the assay (Fig.  11 E, J,N , with higher magnification of CSB in EЈ,JЈ,NЈ). Together, these controls confirm that the LACE signal provides a specific readout of the interaction between each FGF protein and HS 4 (Figure legend continued. ) (J, K1-K3, L1-L3) and Fgf17 protein (M, N1-N3, O1-O3) expression (red) relative to GFP ϩ Zic4-lineage cells (indicated with white arrows) at the GW (K1-K3, N1-N3) and IG (L1-L3, O1-O3) of WT E14.5 embryos. P, E14.5 expression of Hs2st by LacZ staining. Hs2st is expressed most highly at the VZ, with decreasing expression toward the pial surface. Q-V, Fgf17 protein (Q, R) and mRNA (S) expression at the E14.5 CSB of WT and Hs6st1 Ϫ / Ϫ embryos. Fgf17 protein is expressed at low levels at the CSB of WT embryos (Q1, R1). In Hs6st1 Ϫ / Ϫ embryos, the protein expression domain is similar to WT (Q2, R2). Fgf17 mRNA expression is unchanged between WT and Hs6st1 Ϫ / Ϫ embryos (S1, S2). T-V, Fgf17 protein (T, U) and mRNA (V) expression at the E16.5 CSB of WT and Hs6st1 Ϫ / Ϫ embryos. Fgf17 protein is expressed at very low levels at the CSB of both WT (T1, U1) and Hs6st1 Ϫ / Ϫ (T2, U2) embryos. Fgf17 mRNA expression is unchanged between WT (V1) and Hs6st1 Ϫ / Ϫ (V2) embryos. W, Quantification of Fgf17 immunofluorescence signal at E14.5 CSB in WT (blue bar, n ϭ 3 embryos), Hs2st Ϫ / Ϫ (green bar, n ϭ 3 embryos), and Hs6st1 Ϫ / Ϫ (purple bar, n ϭ 3 embryos). Fgf17 protein level is significantly increased compared with WT in Hs2st 
